Back to TrueCost
M2

Mounjaro 2.5 mg KwikPen solution for injection in pre-filled pen

MounjaroPrescription injectable medicine; tirzepatide GLP-1/GIP receptor agonist

Mounjaro 2.5 mg KwikPen solution for injection in pre-filled pen

Mounjaro 2.5 mg/dose KwikPen is a multi-dose pre-filled injection pen manufactured and marketed by Eli Lilly. The 2.5 mg strength is the starter dose. Each pen delivers four once-weekly subcutaneous doses of 2.5 mg tirzepatide in 0.6 mL solution.

UK retail price

£179.00

Verified today.

Estimated landed cost

£29.00

Modelled manufacturing and landed-cost estimate.

Price comparison

Retail vs estimated landed cost

Difference £150
Retail price£179
Estimated landed cost£29

Cost share

16%

of retail price

Retail multiple

6.2×

Retail price divided by estimated landed cost.

Difference

£150.00

Not profit. Other costs sit between landed cost and retail.

Confidence

69%

Evidence and modelling confidence.

Last analysed

today

Retail price checked today.

Price history

UK retail price trend

Verified retail-price checks recorded by TrueCost over time.

Last checked today

Latest

£179.00

Lowest recorded

£179.00

Highest recorded

£179.00

£1797 Sept
1 verified price checkNo overall price change

View individual price checks

1 recorded price checks

7 Sept 2026Verified

Boots Online Doctor – Mounjaro prescription and orders

£179.00Source ↗

Cost model

What makes up the estimated cost?

TrueCost models the major components, manufacturing, assembly, packaging and landed costs required to produce the product.

Tirzepatide active pharmaceutical ingredient

Active ingredient

The pen contains 10 mg of tirzepatide plus manufacturing overfill. Tirzepatide is a complex synthetic peptide rather than a low-cost small-molecule API, so the estimate allows for peptide synthesis, purification, yield loss, analytical testing and pharmaceutical-scale production. Public data do not disclose Lilly's internal API cost.

£12.00

41.4%

Excipients and formulation materials

Raw materials

Includes water for injection, phosphate buffer, sodium chloride, phenol, benzyl alcohol, glycerol and pH-adjustment chemicals. The quantities per pen are small, so the material cost is low relative to the active ingredient.

£0.15

0.5%

Cartridge and primary container components

Physical components

Allowance for the glass or polymer cartridge, stopper, seals and associated primary-container materials holding approximately 2.4 mL of solution plus excess volume.

£1.20

4.1%

Disposable KwikPen mechanical device

Physical components

Covers the pen body, cartridge holder, cap, cap clip, dose mechanism, dose window or indicator, dose knob, plunger components and internal seals. The device has no electronics, but requires precision-moulded and assembled components.

£4.80

16.6%

Sterile formulation, filling and device assembly

Manufacturing process

Includes solution preparation, sterile filtration or aseptic processing, filling into cartridges, pen assembly, in-process controls and allowance for normal production losses. Sterile fill-finish costs are material even when the liquid volume is small.

£4.50

15.5%

Primary and secondary packaging

Packaging

Includes label, folding carton, leaflet, tamper or identification materials and packing operations. Needles are excluded because the research pack states they are not supplied with the pen.

£1.30

4.5%

Quality control, batch release and regulatory production testing

Quality operations

Allocated cost for analytical testing of the API and finished product, sterility or microbiological controls, device-function checks, stability-related release work and batch documentation.

£2.50

8.6%

Direct factory overhead

Factory overhead

Allocation for cleanroom operation, equipment depreciation, utilities, maintenance, production supervision and directly attributable manufacturing support.

£1.80

6.2%

Freight and temperature-controlled logistics to the UK

Logistics

Assumes European production or batch release and consolidated shipment to the UK. The medicine requires refrigerated storage before use, but per-unit freight cost can be modest when shipped in volume.

£0.60

2.1%

Import clearance and duty allowance

Import costs

Small allowance for customs handling, documentation and potentially applicable import charges. The actual duty treatment depends on origin, tariff classification and the specific supply route; this estimate does not assume a substantial tariff.

£0.15

0.5%

More detail

Explore the analysis

Open any section below to see more about the evidence, methodology and assumptions behind this estimate.

Estimated cost range

£18.00 – £45.00

The central TrueCost estimate is a modelled value. The plausible range reflects uncertainty in component pricing, manufacturing, assembly, freight and other landed-cost assumptions.

Analysis freshness

Fresh · Full analysis today

Full TrueCost analysisFresh

7 Sept 2026 · today

Retail priceFresh

7 Sept 2026 · today

Retail prices are rechecked after 30 days when the product is requested. The full manufacturing and landed-cost analysis is refreshed after 180 days.

Evidence quality

7 research sources · 69% confidence

Official product sourceFound
Retail price verifiedFound
Specifications foundFound
Teardown evidenceNot found
Manufacturing locationFound
Overall confidence69%

Research sources

7 sources used

Lilly UK – Current medicines

Official manufacturer websiteProduct identification and manufacturer/brand

Lists Mounjaro among Lilly UK medicines and links the product to Eli Lilly’s UK information resources.

Mounjaro KwikPen 10mg solution for injection in pre-filled pen – UK Summary of Product Characteristics

Regulatory product informationComposition, dosage, packaging, storage and UK authorisation

The UK SmPC covers the 2.5 mg KwikPen presentation and specifies 2.5 mg per 0.6 mL dose, four doses per pen, 2.4 mL total volume, excipients, storage, pack sizes, needles not included and UK marketing authorisation details.

Mounjaro – European Medicines Agency product information

Regulatory product informationManufacturing and batch-release locations; technical specifications

Lists the multi-dose KwikPen presentation and identifies Eli Lilly facilities and Millmount Healthcare facilities in Italy, France, Spain and Ireland in the manufacturer/batch-release information.

What excipients does the Mounjaro KwikPen contain? – Lilly Medical UK

Official manufacturer medical informationFormulation and excipient quantities

Provides the per-dose quantities and purposes of the inactive ingredients, including buffer, tonicity agents, preservatives, vehicle and pH adjusters.

Boots Online Doctor – Mounjaro prescription and orders

Recognised UK retailer/pharmacyCurrent private UK retail price

Lists Mounjaro 2.5 mg, one pen, at £179. The page also confirms the UK product contains tirzepatide.

NHS Business Services Authority – Mounjaro price increase and Drug Tariff redetermination

Official UK reimbursement informationUK NHS reimbursement/list price

Records the 2.5 mg Mounjaro KwikPen reimbursement price as £133 from September 2025, useful as a regulated UK price benchmark but not a private retail price.

Introducing the Mounjaro Pen – Lilly UK patient booklet

Official manufacturer patient informationPen architecture and major components

Illustrates and names the pen cap, cap clip, cartridge, cartridge holder, pen body, dose indicator, plunger, label, dose window, dose knob and red inner seal; it also states that needles are not included.

Model assumptions

6 assumptions

  • The unit contains 10 mg total tirzepatide in 2.4 mL of solution, plus normal manufacturing overfill or priming excess.
  • The pen is manufactured or batch-released in Europe and supplied to the UK, with shipment cost allocated across a pallet or consolidated pharmaceutical shipment.
  • The pen is a disposable multi-dose device with no electronic components and no needles included.
  • Tirzepatide API cost is estimated from commercial synthetic-peptide pharmaceutical manufacturing economics; the actual internal transfer price is not publicly disclosed.
  • The range reflects uncertainty in API pricing, sterile manufacturing yields, quality-control requirements, device procurement costs, cold-chain logistics and country-specific manufacturing arrangements.
  • The estimate is for one pen, not a three-pen pack, and excludes any patient-service or dispensing costs.